Clinical Trial

Affirmative Family and Individual Psychotherapy for Sexual and Gender Minority Adults and Their Nonaccepting Parents

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the efficacy of an LGBTQ-affirmative individual cognitive behavioral psychotherapy (CBT) and LGBTQ-affirmative family therapy (attachment-based family therapy for sexual and gender minority young adults; ABFT-SGM) delivered via telehealth to a sample of sexual and gender minority adults with nonaccepting parent(s) in New York, Pennsylvania, Connecticut, and Israel. The investigators will assess whether both treatments are associated with significant decreases in depressive and anxiety symptoms. The investigators will also assess whether and how each treatment achieves reductions in mental health symptoms through specific mechanisms (e.g., rejection sensitivity, internalized stigma, emotion dysregulation, parental rejection and acceptance).
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2023-03-01; most recent amendment 2026-01-12.
Status change: Not Yet Recruiting → Recruiting 2023-05-16
Trial Details
NCT Number NCT05766592
Lead Sponsor Yale University
Collaborators: Ben-Gurion University of the Negev, Israel Science Foundation
Conditions Mental Health Issue, Parent-Child Relations
Enrollment 124 participants
Start Date 2024-08-13
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-13